The notable advances on interstitial lung disease (ILD) published in Chinese and international authoritative journals from October 2023 to September 2024 were systematically reviewed in this annual review. Advances on pathogenesis, diagnosis, treatment, global and/or Chinese comments and guidelines of idiopathic pulmonary fibrosis, connective tissue disease-associated ILD and sarcoidosis were reviewed in detail in our paper.